<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05016401</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A01491-38</org_study_id>
    <nct_id>NCT05016401</nct_id>
  </id_info>
  <brief_title>Performance and Safety of Use of the &quot;KONTACT PERIO LEVEL&quot; Transgingival Titanium Dental Implant</brief_title>
  <acronym>KPL</acronym>
  <official_title>Multicenter Observational Study Evaluating the Performance and Safety of Use of the &quot;KONTACT PERIO LEVEL&quot; Dental Implant in Routine Clinical Practice.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotech Dental</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotech Dental</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      As part of post-marketing clinical follow-up, BIOTECH DENTAL sets up the collection and&#xD;
      evaluation of clinical data proactively with the aim of confirming the safety, performance as&#xD;
      well as the constantly acceptable nature of the risks identified and of detecting potential&#xD;
      emerging risks with the use of &quot;Kontact Perio Level&quot; implants in everyday practice.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2020</start_date>
  <completion_date type="Anticipated">January 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 6, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate</measure>
    <time_frame>12 months</time_frame>
    <description>For an implant to be declared &quot;successful&quot; it must meet the following criteria as defined by Albrektsson et al. 1986 adapted: Lack of mobility ; Absence of pain ; Lack of radiolucency around the implant ; Absence of bleeding and inflammation ; No significant peri-implant periodontal pocket (≤4mm) ; Stability of the peri-implant bone level over time with marginal bone loss ≤1.5 mm the first year and ≤0.2 mm the following years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone Level</measure>
    <time_frame>12 months</time_frame>
    <description>Peri-implant marginal bone loss and / or regrowth is calculated using x-rays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic complications</measure>
    <time_frame>12 months</time_frame>
    <description>All prosthetic complications having affected the restorations on implants, from the placement of the provisional restorations until the end of the study, are recorded (loosening of the abutment screws, the fracture of the abutment, loss of retention, fracture, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary stability</measure>
    <time_frame>surgical time</time_frame>
    <description>Value of the torque during implant placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate</measure>
    <time_frame>12 months</time_frame>
    <description>An implant is classified as &quot;surviving&quot; if it is still in operation at some point t</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Factors that influence the survival and success rate</measure>
    <time_frame>12 months</time_frame>
    <description>Univariate statistical analysis of the success and survival rate as a function of: age; sex; bone density; site of implantation; bone graft; type of prosthesis; jaw type;...</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-implantitis</measure>
    <time_frame>12 months</time_frame>
    <description>Number of peri-implantitis (inflammatory disease causing bone loss around an implant)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>12 months</time_frame>
    <description>Evolution of the quality of life score calculated using GOHAI (General Oral Health Assessment Index)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Tooth Loss</condition>
  <condition>Partially Edentulous Maxilla</condition>
  <condition>Partially Edentulous Mandible</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>KONTACT PERIO LEVEL (KPL)</intervention_name>
    <description>The Kontact™ Perio Level is an implant with a transgingival neck that facilitates one-step surgery.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient eligible and planned for an implant-supported prosthetic restoration according&#xD;
        to the instructions for use of the KONTACT PERIO LEVEL dental implant.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Edentulous patient requiring the placement of one (or more) dental implant (s) in the&#xD;
             maxilla or mandibular&#xD;
&#xD;
          -  Age ≥ 18 years old&#xD;
&#xD;
          -  Good general health (ASA score between [1-2])&#xD;
&#xD;
          -  Sufficient volume and bone quality (with or without bone graft) to support the implant&#xD;
&#xD;
          -  Non-objection of the patient for the collection of his medical data as part of the&#xD;
             study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Poor oral hygiene&#xD;
&#xD;
          -  Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints&#xD;
&#xD;
          -  Infections and oral inflammation such as active periodontitis, active gingivitis&#xD;
&#xD;
          -  Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may&#xD;
             compromise peri-implant tissue healing&#xD;
&#xD;
          -  Heavy smoker (&gt; 10 cigarettes / day)&#xD;
&#xD;
          -  Patient with a pathology or immunosuppressive therapy such as chemotherapy,&#xD;
             radiotherapy&#xD;
&#xD;
          -  Patient on prolonged steroid therapy&#xD;
&#xD;
          -  Titanium / titanium alloy allergy&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Pregnant woman (or likely to be pregnant); or breastfeeding&#xD;
&#xD;
          -  Difficulty of medical follow-up patients with geographical, social or psychological&#xD;
             constraints&#xD;
&#xD;
          -  Persons deprived of liberty or guardianship&#xD;
&#xD;
          -  Involuntary / patient refusal to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ludovic HUET</last_name>
    <phone>0634125270</phone>
    <email>l.huet@biotech-dental.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pascal BREYSSE</last_name>
    <email>p.breysse@biotech-dental.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Coordinating Investigator</name>
      <address>
        <city>Bandol</city>
        <zip>83150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael DE GEA, Dr</last_name>
      <phone>0494295807</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth, Edentulous</mesh_term>
    <mesh_term>Tooth Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

